BRPI0409958A - quinolinas de benzofuranil- e benzotienil-piperazinil quinolinas e métodos para o seu uso - Google Patents

quinolinas de benzofuranil- e benzotienil-piperazinil quinolinas e métodos para o seu uso

Info

Publication number
BRPI0409958A
BRPI0409958A BRPI0409958-3A BRPI0409958A BRPI0409958A BR PI0409958 A BRPI0409958 A BR PI0409958A BR PI0409958 A BRPI0409958 A BR PI0409958A BR PI0409958 A BRPI0409958 A BR PI0409958A
Authority
BR
Brazil
Prior art keywords
quinolines
benzofuranyl
benzothienyl
methods
piperazinyl
Prior art date
Application number
BRPI0409958-3A
Other languages
English (en)
Inventor
Aranapakam Mudumbai Venkatesan
Osvaldo Dos Santos
Magda Asselin
George Theodore Grosu
Deborah A Evrard
Richard Eric Mewshaw
Kristin Meagher
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0409958A publication Critical patent/BRPI0409958A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"BENZOFURANIL- E BENZOTIENIL-PIPERAZINIL QUINOLINAS E MéTODOS PARA O SEU USO". Derivados de benzofuranil e benzotienil-piperazinil quinolina e composições contendo tais compostos são apresentados. São também apresentados métodos de uso de derivados de benzofuranil e benzotienilpiperazinil quinolina e composições contendo tal composição no tratamento e/ou prevenção de distúrbios relacionados com a serotonina, tais como depressão e ansiedade. Além disso, processos para a preparação de derivados de benzofuranil e benzotienil-piperazinil quinolina são apresentados.
BRPI0409958-3A 2003-05-02 2004-04-30 quinolinas de benzofuranil- e benzotienil-piperazinil quinolinas e métodos para o seu uso BRPI0409958A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46736803P 2003-05-02 2003-05-02
US10/835,185 US7276603B2 (en) 2003-05-02 2004-04-29 Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use
PCT/US2004/013350 WO2004099191A2 (en) 2003-05-02 2004-04-30 Benzofuranyl-and benzothienyl-piperazinyl quinolines as serotonin reuptake inhib itors

Publications (1)

Publication Number Publication Date
BRPI0409958A true BRPI0409958A (pt) 2006-04-25

Family

ID=33436728

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409958-3A BRPI0409958A (pt) 2003-05-02 2004-04-30 quinolinas de benzofuranil- e benzotienil-piperazinil quinolinas e métodos para o seu uso

Country Status (8)

Country Link
US (1) US7276603B2 (pt)
EP (1) EP1641785A2 (pt)
JP (1) JP2006525348A (pt)
AU (1) AU2004236215A1 (pt)
BR (1) BRPI0409958A (pt)
CA (1) CA2524324A1 (pt)
MX (1) MXPA05011677A (pt)
WO (1) WO2004099191A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7390670B2 (en) * 2003-02-20 2008-06-24 Lumigen, Inc. Signalling compounds and methods for detecting hydrogen peroxide
KR100659498B1 (ko) * 2005-03-10 2006-12-20 애니젠 주식회사 벤조퓨로인돌계 칼륨 채널 개시제
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
RU2008147894A (ru) * 2006-05-05 2010-06-10 Дау Глобал Текнолоджиз Инк. (Us) Комплексы гафния с гетероциклическими органическими лигандами
TW200808730A (en) * 2006-06-09 2008-02-16 Wyeth Corp Process for synthesizing piperazine-piperidine compounds
AR065376A1 (es) * 2007-02-16 2009-06-03 Wyeth Corp Formulacion de pastillas de liberacion sostenida de antagonistas y agonistas de piperazina - piperidina del receptor 5 ht1a que tienen disolucion instestinal mejorada
CN101619056B (zh) * 2008-07-02 2013-07-17 石药集团中奇制药技术（石家庄）有限公司 苯并噻吩烷醇哌嗪衍生物及其作为抗抑郁症药物的应用
WO2015014256A1 (en) 2013-07-29 2015-02-05 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use thereof
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
KR20240058859A (ko) * 2021-08-12 2024-05-03 쿨레온 엘엘씨 환각성 및 비환각성 세로토닌 수용체 작용제 및 이의 제조 및 사용 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830312D0 (en) 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
ZA929008B (en) 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
US5468768A (en) 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
JP2002510682A (ja) 1998-04-08 2002-04-09 アメリカン・ホーム・プロダクツ・コーポレイション うつ病治療用のインドール−３−イル−シクロヘキシルアミン誘導体（５−ｈｔ１受容体拮抗薬）
TW520367B (en) 1998-04-29 2003-02-11 Wyeth Corp Indolyl derivatives as serotonergic agents
HUP0101475A3 (en) 1998-06-19 2003-01-28 Lundbeck & Co As H 4,5,6 and 7-indole and indoline derivatives, their preparation and use
AR021509A1 (es) 1998-12-08 2002-07-24 Lundbeck & Co As H Derivados de benzofurano, su preparacion y uso
ES2219302T3 (es) 1999-01-07 2004-12-01 Wyeth Derivados de arilpiperazinil-ciclohexilindol para el tratamiento de la depresion.
US6313126B1 (en) * 1999-01-07 2001-11-06 American Home Products Corp Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
AR022303A1 (es) 1999-01-22 2002-09-04 Lundbeck & Co As H Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion
WO2001014330A2 (en) 1999-08-23 2001-03-01 Solvay Pharmaceuticals B.V. Phenylpiperazines as serotonin reuptake inhibitors
FR2799463B1 (fr) 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
ES2188344B1 (es) 2000-11-29 2004-09-16 Laboratorios Vita, S.A. Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.

Also Published As

Publication number Publication date
WO2004099191A3 (en) 2005-02-10
CA2524324A1 (en) 2004-11-18
US7276603B2 (en) 2007-10-02
JP2006525348A (ja) 2006-11-09
AU2004236215A1 (en) 2004-11-18
EP1641785A2 (en) 2006-04-05
MXPA05011677A (es) 2005-12-15
US20050059673A1 (en) 2005-03-17
WO2004099191A2 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
DE60205234D1 (de) 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten
DE60108236D1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
ATE435210T1 (de) Tetrahydroisochinolylacetamidderivate zur verwendung als orexinrezeptorantagonisten
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
ATE469892T1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
DK1499607T3 (da) 4-(piperidyl- og pyrrolidyl-alkyl-ureido)-quinoliner som urotensin II-receptorantagonister
CY1109808T1 (el) Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α
SE0403171D0 (sv) New compounds
ATE383345T1 (de) Quinoxalin-3-on-verdindungen als orexin-rezeptor antagonisten.
BRPI0409958A (pt) quinolinas de benzofuranil- e benzotienil-piperazinil quinolinas e métodos para o seu uso
DK1725536T3 (da) Imidazolin-derivater med CB1-antagonistisk aktivitet
ATE418550T1 (de) 8-(1-piperazinyl)-chinolinderivate und deren verwendung bei der behandlung von zns- erkrankungen
MXPA05004273A (es) Derivados de fenilalquil y piridilalquil piperazina.
SE0303280D0 (sv) Novel compounds
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
DE60225155D1 (de) 3-substituierte 6,7-dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel
ATE373000T1 (de) Pyrazolopyridin-derivate als antiherpesmittel
BRPI0410026A (pt) derivados de 3-amino-croman quinolina
DE60310730D1 (de) Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
PE20030125A1 (es) PIRIDO[1,2-c]PIRIMIDINA COMO AGENTES ANTIBACTERIANOS
MXPA05013368A (es) Derivados de indolilo biciclico y metodos para su uso como agentes serotonergicos.
MXPA01009174A (es) Antagonistas de endotelina novedosos derivados de piridazina.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.